Hunter Heidi 4
4 · SUTRO BIOPHARMA, INC. · Filed Nov 22, 2021
Insider Transaction Report
Form 4
Hunter Heidi
Director
Transactions
- Award
Stock Option (right to buy Common Stock)
2021-11-19+24,000→ 24,000 totalExercise: $17.56Exp: 2031-11-18→ Common Stock (24,000 underlying) - Award
Stock Option (right to buy Common Stock)
2021-11-19+9,884→ 9,884 totalExercise: $17.56Exp: 2031-11-18→ Common Stock (9,884 underlying)
Footnotes (2)
- [F1]The option vests as to 2.778% of the total shares monthly, beginning on December 19, 2021, with 100% of the total shares vested and exercisable on November 19, 2024, subject to the reporting person's provision of service to the issuer on each vesting date.
- [F2]The option vests as to 15.59% of the total shares monthly beginning on December 19, 2021 through May 19, 2022, and 6.45% on June 2, 2022, with 100% of the total shares vested and exercisable on the issuer's 2022 annual meeting of stockholders, subject to the reporting person's provision of service to the issuer on each vesting date.